STAT3 and hepatocellular carcinoma: Conversely, it was found that upon inhibition of mTOR in macrophages in hepatocellular carcinoma (HCC), STAT3 decreased the secretion of both IL-10 and IL-12 and inhibited angiogenesis in vivo [80].